
Aradhana Sasan
Examiner (ID: 9005, Phone: (571)272-9022 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 1310 |
| Issued Applications | 752 |
| Pending Applications | 117 |
| Abandoned Applications | 467 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18477066
[patent_doc_number] => 11690789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Multiple-fill/chamber softgel die
[patent_app_type] => utility
[patent_app_number] => 16/468844
[patent_app_country] => US
[patent_app_date] => 2017-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 23
[patent_no_of_words] => 10693
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16468844
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/468844 | Multiple-fill/chamber softgel die | Dec 21, 2017 | Issued |
Array
(
[id] => 13325795
[patent_doc_number] => 20180214435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => ORAL PHARMACEUTICAL DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 15/853013
[patent_app_country] => US
[patent_app_date] => 2017-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15853013
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/853013 | Oral pharmaceutical dosage forms | Dec 21, 2017 | Issued |
Array
(
[id] => 13368667
[patent_doc_number] => 20180235874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => Coconut Oil and Honey Throat Lozenge
[patent_app_type] => utility
[patent_app_number] => 15/851225
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15851225
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/851225 | Coconut Oil and Honey Throat Lozenge | Dec 20, 2017 | Abandoned |
Array
(
[id] => 15342477
[patent_doc_number] => 20200009130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => OCULAR DISTRIBUTION AND PHARMACOKINETICS OF LIFITEGRAST FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/470005
[patent_app_country] => US
[patent_app_date] => 2017-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16470005
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/470005 | OCULAR DISTRIBUTION AND PHARMACOKINETICS OF LIFITEGRAST FORMULATIONS | Dec 14, 2017 | Abandoned |
Array
(
[id] => 12831580
[patent_doc_number] => 20180169032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => DELIVERY OF HYDROPHOBIC ACTIVE AGENTS FROM HYDROPHILIC POLYETHER BLOCK AMIDE COPOLYMER SURFACES
[patent_app_type] => utility
[patent_app_number] => 15/840540
[patent_app_country] => US
[patent_app_date] => 2017-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15840540
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/840540 | Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces | Dec 12, 2017 | Issued |
Array
(
[id] => 12880306
[patent_doc_number] => 20180185277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => OPTIMIZED PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CONDITIONS OF THE ESOPHAGUS
[patent_app_type] => utility
[patent_app_number] => 15/833428
[patent_app_country] => US
[patent_app_date] => 2017-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15833428
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/833428 | Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus | Dec 5, 2017 | Issued |
Array
(
[id] => 15338703
[patent_doc_number] => 10525005
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Cromolyn compositions and methods thereof
[patent_app_type] => utility
[patent_app_number] => 15/830980
[patent_app_country] => US
[patent_app_date] => 2017-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12450
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15830980
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/830980 | Cromolyn compositions and methods thereof | Dec 3, 2017 | Issued |
Array
(
[id] => 12580980
[patent_doc_number] => 20180085489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => AMINE-FUNCTIONALIZED POLYMERIC COMPOSITIONS FOR MEDICAL DEVICES
[patent_app_type] => utility
[patent_app_number] => 15/830528
[patent_app_country] => US
[patent_app_date] => 2017-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15830528
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/830528 | Amine-functionalized polymeric compositions for medical devices | Dec 3, 2017 | Issued |
Array
(
[id] => 12603201
[patent_doc_number] => 20180092897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS
[patent_app_type] => utility
[patent_app_number] => 15/830727
[patent_app_country] => US
[patent_app_date] => 2017-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15830727
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/830727 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | Dec 3, 2017 | Abandoned |
Array
(
[id] => 12746389
[patent_doc_number] => 20180140630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => COMBINATION OF AN H2-RECEPTOR ANTAGONIST, ANTACID, AND ALGINIC ACID TO TREAT EPISODIC HEARTBURN
[patent_app_type] => utility
[patent_app_number] => 15/820821
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15820821
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/820821 | COMBINATION OF AN H2-RECEPTOR ANTAGONIST, ANTACID, AND ALGINIC ACID TO TREAT EPISODIC HEARTBURN | Nov 21, 2017 | Abandoned |
Array
(
[id] => 15694495
[patent_doc_number] => 10603409
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-31
[patent_title] => Bone void filler having calcium coatings
[patent_app_type] => utility
[patent_app_number] => 15/819343
[patent_app_country] => US
[patent_app_date] => 2017-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 19693
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15819343
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/819343 | Bone void filler having calcium coatings | Nov 20, 2017 | Issued |
Array
(
[id] => 12785899
[patent_doc_number] => 20180153802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/816154
[patent_app_country] => US
[patent_app_date] => 2017-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15816154
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/816154 | Orally administered corticosteroid compositions | Nov 16, 2017 | Issued |
Array
(
[id] => 13519467
[patent_doc_number] => 20180311276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => Method and Apparatus for Treating Oral Disease in Animals
[patent_app_type] => utility
[patent_app_number] => 15/806025
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15806025
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/806025 | Method and Apparatus for Treating Oral Disease in Animals | Nov 6, 2017 | Abandoned |
Array
(
[id] => 13519247
[patent_doc_number] => 20180311166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => TERNARY MIXTURE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 15/804608
[patent_app_country] => US
[patent_app_date] => 2017-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15804608
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/804608 | TERNARY MIXTURE FORMULATIONS | Nov 5, 2017 | Abandoned |
Array
(
[id] => 13165539
[patent_doc_number] => 10098861
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-10-16
[patent_title] => Pharmaceutical composition comprising sodium benzoate compound and clozapine, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/792088
[patent_app_country] => US
[patent_app_date] => 2017-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12124
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15792088
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/792088 | Pharmaceutical composition comprising sodium benzoate compound and clozapine, and uses thereof | Oct 23, 2017 | Issued |
Array
(
[id] => 13968227
[patent_doc_number] => 10213446
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Method of treating acute coronary syndromes
[patent_app_type] => utility
[patent_app_number] => 15/791816
[patent_app_country] => US
[patent_app_date] => 2017-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 8291
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15791816
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/791816 | Method of treating acute coronary syndromes | Oct 23, 2017 | Issued |
Array
(
[id] => 14548771
[patent_doc_number] => 10342823
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-09
[patent_title] => Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne
[patent_app_type] => utility
[patent_app_number] => 15/787565
[patent_app_country] => US
[patent_app_date] => 2017-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13702
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15787565
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/787565 | Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne | Oct 17, 2017 | Issued |
Array
(
[id] => 17679946
[patent_doc_number] => 11364176
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Comestible capsule and method and apparatus for manufacturing same
[patent_app_type] => utility
[patent_app_number] => 16/345360
[patent_app_country] => US
[patent_app_date] => 2017-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 21
[patent_no_of_words] => 4117
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16345360
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/345360 | Comestible capsule and method and apparatus for manufacturing same | Oct 15, 2017 | Issued |
Array
(
[id] => 17741398
[patent_doc_number] => 11389443
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
[patent_app_type] => utility
[patent_app_number] => 15/785080
[patent_app_country] => US
[patent_app_date] => 2017-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 20369
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15785080
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/785080 | Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment | Oct 15, 2017 | Issued |
Array
(
[id] => 13165793
[patent_doc_number] => 10098989
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-16
[patent_title] => Coatings for controlled release of water soluble drugs
[patent_app_type] => utility
[patent_app_number] => 15/730006
[patent_app_country] => US
[patent_app_date] => 2017-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 11061
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15730006
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/730006 | Coatings for controlled release of water soluble drugs | Oct 10, 2017 | Issued |